dc.contributor.advisor | Hak, Sjoerd | |
dc.contributor.advisor | Widerøe, Marius | |
dc.contributor.advisor | Haraldseth, Olav | |
dc.contributor.author | Sofias, Alexandros Marios | |
dc.date.accessioned | 2020-03-06T11:59:09Z | |
dc.date.available | 2020-03-06T11:59:09Z | |
dc.date.issued | 2019 | |
dc.identifier.isbn | 978-82-326-4337-0 | |
dc.identifier.issn | 1503-8181 | |
dc.identifier.uri | http://hdl.handle.net/11250/2645780 | |
dc.language.iso | eng | nb_NO |
dc.publisher | NTNU | nb_NO |
dc.relation.ispartofseries | Doctoral theses at NTNU;2019:369 | |
dc.title | Unraveling the multifaceted in vivo fate of cancer nanomedicine | nb_NO |
dc.type | Doctoral thesis | nb_NO |
dc.subject.nsi | VDP::Technology: 500::Medical technology: 620 | nb_NO |
dc.description.localcode | digital fulltext is not avialable | nb_NO |